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 1 
ABSTRACT 1 
 Eleven exopolysaccharides (EPS) isolated from different human intestinal 2 
Bifidobacterium strains were tested in fecal slurry batch cultures and compared with glucose 3 
and the prebiotic inulin, for their ability to act as fermentable substrates for intestinal bacteria. 4 
During incubation, the increase of short chain fatty acids (SCFA) was considerably more 5 
pronounced in cultures with EPS, glucose, and inulin than in controls without carbohydrates 6 
added, indicating that the substrates assayed were fermented by intestinal bacteria. Shifts in 7 
molar proportions of SCFA during incubation with EPS and inulin caused a decrease on the 8 
acetic to propionic acids ratio, a possible indicator of the hypolipidemic effect of prebiotics, 9 
with the lowest values for this parameter obtained for EPS from the species B. longum, and 10 
from the strain B. pseudocatenulatum C52. This behaviour was contrary to that found with 11 
glucose, carbohydrate not considered as a prebiotic and for which a clear increase of this ratio 12 
was obtained during incubation. Quantitative real time PCR showed that EPS exerted a 13 
moderate bifidogenic effect, which was comparable for some polymers to inulin, but which 14 
was lower to that found for glucose. PCR-DGGE of 16S rDNA fragments using universal 15 
primers was employed to analyse microbial groups other than bifidobacteria. Changes in 16 
banding patterns during incubation with EPS indicated microbial rearrangements of 17 
Bacteroides and Escherichia coli relatives. Moreover, the use of EPS from B. 18 
pseudocatenulatum accounted, in fecal cultures from some individuals, for the prevalence of 19 
Desulfovibrio and Faecalibacterium prausnitzii whereas incubation with EPS from B. longum 20 
supported populations close to Anaerostipes, Prevotella, and/or Oscillospira. Thus, EPS 21 
synthesized by intestinal bifidobacteria could act as fermentable substrates for 22 
microorganisms in the human gut environment, modifying interactions among intestinal 23 
populations.  24 
 25 
 2 
 1 
INTRODUCTION 2 
 The human colon is inhabited by a complex bacterial community dominated by 3 
obligate anaerobes that reach counts over 1011 bacteria per gram of content. Colonic bacteria 4 
obtain energy by fermenting a variety of dietary compounds that are not digested by the host. 5 
The fermentation of non-digestible compounds from the diet, which include mainly plant cell 6 
wall polysaccharides, and some storage polysaccharides and oligosaccharides, has a major 7 
influence on host health (6). Short-chain fatty acids (SCFA) are the main products arising 8 
from microbial fermentation of these carbohydrates and they exert health benefits by 9 
providing energy to the colonic epithelium, modulating some metabolic processes, 10 
suppressing pathogenic bacteria in the intestine and exerting immune stimulation (7, 42). 11 
Specific carbohydrates are now being widely used as prebiotic substrates based on the 12 
concept that they stimulate particular beneficial bacteria (19) and that, at the same time, are 13 
able to reduce the populations of non-utilizing and non-beneficial bacteria by competition. 14 
Inulin and fructo-oligosaccharides (FOS) were originally proposed as prebiotics that 15 
selectively stimulate bifidobacteria, intestinal microorganisms considered beneficial and that 16 
are being extensively used as probiotics (31). Experimental evidence confirmed the 17 
bifidogenic effect of inulin and FOS (18, 28, 48). However, additional studies using 18 
molecular techniques, have revealed that a variety of other bacterial groups, including 19 
Clostridium-related species, also respond to inulin or FOS (13, 26). Among the possible 20 
explanations for the diversity in response to prebiotics is that complex gut microbial 21 
communities involve extensive metabolic interactions. Metabolic products produced from 22 
dietary prebiotics by one bacterial species may provide substrates to support the growth of 23 
other populations. Such a mechanism, termed “cross-feeding” can result in metabolic 24 
consequences that would not be predicted simply from the substrate preferences of isolated 25 
 3 
groups of bacteria. These interactions may lead to changes in bacterial communities within 1 
the colon following pH variations or the release of fermentation and other metabolic products 2 
formed by the bacterial metabolic activity (2, 15, 16, 39, 47).  3 
 Many strains of lactic acid bacteria (LAB) and bifidobacteria are able to produce 4 
exopolysaccharides (EPS). The physiological functions of these carbohydrate polymers have 5 
not yet been clearly determined. It has been suggested that EPS produced by some LAB could 6 
exert beneficial effects on human health. Among these effects the possibility of acting as 7 
prebiotic substrates has been demonstrated successfully to date by Korakli and co-workers 8 
(27) for a fructan-tpye EPS produced by one strain of Lactobacillus sanfranciscensis. There 9 
was evidence of a bifidogenic effect for the levan-type EPS produced by another strain of the 10 
same species (8). We have recently found that some human intestinal Bifidobacterium isolates 11 
were able to produce EPS and some of them harboured genes relating to the synthesis of 12 
heteropolysaccharides (36). In the present work we have investigated the ability of some of 13 
these EPS synthesized by intestinal bifidobacteria to act as fermentable substrates for 14 
microorganisms inhabiting the human colon as well as their potential bifidogenic effect.   15 
 16 
 17 
MATERIAL AND METHODS  18 
Bacterial strains and culture conditions 19 
 The EPS-producing strains (Table 1) employed in this study have been previously 20 
isolated from biological samples of ten healthy adult volunteers with the approval of the 21 
Regional Ethics Committee (Asturias, Spain) and were identified by 16S rDNA sequencing. 22 
Volunteers mainly provided fecal samples and some of them also colonic or rectal mucosal 23 
samples that were obtained during routine colonoscopies (10). Bifidobacteria were grown in 24 
MRSC broth [MRS (BioKar Diagnostics, Beauvais, France) supplemented with 0.25% 25 
 4 
(wt/vol) L-cysteine (Sigma Chemical Co., St. Luis, MO)] and incubated at 37ºC for 24 h 1 
under anaerobiosis [10% (vol/vol) H2, 10% CO2 and 80% N2] in an anaerobic  chamber Mac 2 
500 (Don Whitley Scientific, West Yorkshire, UK). After centrifugation, microorganisms 3 
were resuspended in MRSC broth containing 20% glycerol and kept at -80ºC until use. Prior 4 
performing experiments, the correct identity of strains was corroborated by 16S rDNA 5 
sequencing (Table 1).  6 
 7 
EPS isolation 8 
 The EPS fraction of each strain was isolated from the cellular biomass harvested 9 
from agar-MRSC plates (35). Strains were grown by creating a culture lawn with sterile glass 10 
beads on the surface of agar-MRSC plates that were then incubated under anaerobic 11 
conditions at 37ºC for 5 days. Cell biomass was collected using 2 ml of ultrapure water per 12 
plate and the resulting volume was mixed with 1 vol of 2 M NaOH. The suspension was 13 
stirred overnight at room temperature to favour the release of the polymer from the cellular 14 
surface. Cells were removed by centrifugation and EPS was precipitated from the 15 
supernatants during 48 h at 4ºC using 2 vol of cold absolute ethanol. After centrifugation, the 16 
EPS fraction was resuspended in ultrapure water and dialysed for 3 days at 4ºC with daily 17 
changes of water, using dialysis tubes (Sigma) of 12 to 14 KDa molecular mass cut off. 18 
Finally, the dialysed EPS fractions were freeze-dried.  19 
 20 
Fecal batch culture fermentations 21 
 Three independent fecal batch fermentations, each of them corresponding to samples 22 
of three different donors, were carried out in the carbohydrate-free basal medium (CFBM) 23 
previously described by Al-Tamimi and co-workers (1). Briefly, the medium contained 24 
peptone water (2 g/liter), yeast extract (2 g/liter), sodium chloride (0.1 g/liter), dipotassium 25 
 5 
phosphate (0.04 g/liter), magnesium sulfate (0.01 g/liter), hexahydrated calcium chloride 1 
(0.01 g/liter), monosodium carbonate (2 g/liter), L-cysteine (2.5 g/liter) , bile bovine (0.5 2 
g/liter), Tween 80 (2 ml), hemin (50 mg/ml), and vitamin K (10 µl).  3 
For each batch, CFBM was distributed into different glass tubes (2.5 ml per tube) that 4 
were added with 15 mg of the EPS-fractions isolated from 11 Bifidobacterium strains (Table 5 
1), glucose, or inulin (Sigma). One additional tube was kept without adding carbon source and 6 
was used as a control. After complete dissolution of the carbon sources and sterilization 7 
(120ºC, 15 min) the tubes were maintained overnight in anaerobiosis at 37ºC before use.  8 
 The fecal slurry inocula were prepared as follows: feces from three healthy adults (2 9 
women and 1 man, 25 to 37 years old) who had not recently received antibiotics, were 10 
separately diluted 1/10 in sterile 0.17 M phosphate buffered saline (PBS) pH 7.3 and 11 
homogenised with a Lab-Blender 400 stomacher (Seward Medical, London, UK) for 2 min. 12 
The fecal homogenates of each donor (10 ml) were poured into 90 ml of CFBM and allowed 13 
to stabilize by being kept overnight at 37ºC under anaerobic conditions. Control and tubes 14 
containing the different EPS fractions, glucose or inulin, were mixed with 2.5 ml of the 15 
stabilised fecal slurry. Fermentations were carried out under anaerobic conditions at 37ºC for 16 
5 days. Samples were taken at time 0, 24 h and 5 days. 800 µl of cultures were centrifuged 17 
(12000 x g, 10 min) each time, and pellets and supernatants were collected.   18 
 Determination of pH in controls at time 0 and after 5 days of incubation was carried 19 
out by using pH-indicator strips (Merck, Darmstadt, Germany) following the manufacturer’s 20 
instructions.  21 
 22 
Analysis of SCFA in fecal batch cultures by GC-MS 23 
 Cell-free supernatants from fecal batch cultures were filtered through 0.2 µm filters 24 
and mixed with 1/10 of ethyl-butyric (2 mg/ml) as an internal standard (IS) and stored at -25 
 6 
80ºC until analysis. 1 
 A system composed of a gas chromatograph (GC) 6890N (Agilent Technologies Inc., 2 
Palo Alto, CA) connected to a mass spectrometry (MS) 5973N detector (Agilent) was used to 3 
quantify the SCFA. Data were collected with the Enhanced ChemStation G1701DA software 4 
(Agilent). Samples (1 µl), prepared as previously described, were directly injected into the GC 5 
equipped with an HP-Innowax capillary column (60 length by 0.25 mm internal diameter, 6 
with a 0.25 µm film thickness; Agilent) using He as the gas carrier with a constant flow of 1.5 7 
ml/min. The temperature of the injector was kept at 220ºC and the split ratio was 50:1. 8 
Chromatographic conditions were as follows: initial oven temperature of 120ºC, 5ºC/min up 9 
to 180ºC, 1 min at 180ºC and for cleaning the column 20ºC/min up to 220ºC. The column was 10 
directly connected to the MS detector and the electron impact energy was set to 70 eV. The 11 
data collected were in the range of 25 to 250 atomic mass units (at 3.25 scans/s). SCFA were 12 
identified by comparing their mass spectra with those held in the HP-Wiley 138 library 13 
(Agilent) and by comparing their retention times with those of the corresponding standards 14 
(Sigma). The peaks were quantified as the relative TIC abundance with respect to the IS. The 15 
concentration (mM) of each SCFA was calculated using the linear regression equations (R2 ≥ 16 
0.99) from the corresponding curves of standards obtained with six different concentrations. 17 
Total SCFA concentrations were calculated as the sum of the three major SCFA (acetic + 18 
propionic + butyric). The molar proportion of each SCFA was obtained as the concentration 19 
percentage with respect to the total SCFA.  20 
 21 
DNA extraction 22 
 DNA was extracted from pellets harvested from 800 µl of fecal batch cultures. Cells 23 
were washed once in PBS buffer and DNA was extracted with the QIAamp DNA Stool Kit 24 
(Qiagen GmbH, Hilden Germany) following the manufacturer’s instructions. Purified DNA 25 
 7 
samples were stored at -20ºC until use.  1 
 2 
Analysis of bifidobacteria by quantitative real-time PCR 3 
 The quantification of the Bifidobacterium population in fecal batch cultures was 4 
performed by quantitative real-time PCR using previously described genus-specific primers 5 
(20).   6 
 All reactions were performed on MicroAmp optical plates sealed with MicroAmp 7 
optical caps (Applied Biosystems, Foster City,CA) and amplifications were carried out in a 8 
7500 Fast Real Time PCR System (Applied Biosystems) using the SYBR Green PCR Master 9 
Mix (Applied Biosystems). 1 µl of purified DNA was used as the template in the 25 µl PCR 10 
reaction. Thermal cycling consisted of an initial cycle of 95oC 10 min followed by 40 cycles 11 
of 95oC 15 s and 60ºC 1 min. Standard curves were made with the strain Bifidobacterium 12 
longum NCIMB8809 which was grown overnight in MRSC under anaerobic conditions. 13 
Standard curves were obtained by plotting the Ct values obtained for the standard culture as a 14 
linear function of the base-10 logarithm of the initial number of cells in the culture 15 
determined by plate counting. The number of Bifidobacterium cells in fecal samples was 16 
determined by comparing the Ct values obtained to the standard curve. Samples were analysed 17 
by duplicate in at least two independent PCR runs.  18 
 19 
Analysis of the fecal microbiota by PCR-DGGE 20 
 The evolution of the intestinal microbiota during fecal batch fermentations was 21 
analysed by partial amplification of the 16S rRNA gene using universal primers. The PCR 22 
products were detected by denaturing gradient gel electrophoresis (DGGE) and specific DNA 23 
bands were selected taking into account differences observed among EPS and individuals. 24 
Bands were identified by sequencing and comparison with those sequences held in GenBank 25 
 8 
database.  1 
 Primers 357F (5´-TAC GGG AGG CAG CAG-3´) and 518R (5´-ATT ACC GCG 2 
GCT GCT GG-3´) were used to amplify the V3 variable region of the 16S rRNA gene (32). 3 
An additional GC-clamp (5´-CGC CCG CCG CGC GCG GCG GGC GGG GCG GGG GCA 4 
CGG GGG -3´) was also added to 357F primer to obtain the primer 357F-GC. Amplifications 5 
were performed in an iCycler apparatus (Bio-Rad Laboratories, Hercules, CA). The reaction 6 
mixture (50 µl) contained 0.25 µM of each 357F-GC and 518R primers, 200 µM of each 7 
dNTP (Amersham Bioscience, Upsala, Sweden), 2.5 U Taq polymerase (Eppendorf, 8 
Hamburg, Germany) and 3 µl of DNA. The amplification program was: 94ºC for 5 min; 35 9 
cycles of 94ºC for 30 s, 56ºC for 30 s and 68ºC for 40 s; and a final extension step of 68ºC for 10 
10 min. The PCR-products were separated by DGGE in a DCode system (Rio-Rad) on 8% 11 
(vol/vol) polyacrylamide (37.5:1 acrylamide-bisacrylamide, Bio-Rad) gels (dimensions 200 x 12 
200 x 1 mm) containing a 40% to 60% gradient of urea-formamide in Tris-acetate-EDTA 13 
(TAE) buffer (50x: 2 M Tris, 1 M acetic acid, 50 mM EDTA, pH 8.0). The solution 40%-14 
gradient contained 20 ml acrylamide-bisacrylamide, 2 ml 50x TAE, 16 ml formamide and 15 
18.8 g urea; the solution 60%-gradient contained 20 ml acrylamide-biscarylamide, 2 ml 50x 16 
TAE, 24 ml formamide and 25.2 g urea. An amount of 17 ml of each solution was mixed with 17 
153 µl of 10% (wt / vol) ammonium persulfate and 15.3 µl TEMED. Gels were made with a 18 
475 Gradient Delivery system (Bio-Rad). Electrophoresis was performed at 85 V in TAE (1x) 19 
buffer at a constant temperature of 60ºC during 16 h. The gels were stained with ethidium 20 
bromide for 30 min, washed with ultrapure water and visualized and photographed under UV 21 
light in a Gel Doc 2000 system with the Quantity One software (Bio-Rad).  22 
 Bands of DNA were excised from gels with a plastic tip, poured into 50 µl ultrapure 23 
water and kept overnight at 4ºC. These DNA samples were used to perform a second PCR 24 
amplification using the primers 357F (without GC-clamp) and 518R under the conditions 25 
 9 
previously indicated. The PCR-products were purified using the GenElute PCR clean-up kit 1 
(Sigma). Automated sequencing of one strand of PCR products was done at Secugen S.L. 2 
(Madrid, Spain) with primer 518R in a gene sequencer ABI PRISM (Applied Biosystems, 3 
Foster City, CA). The basic local alignment search tool (BLAST) program was used to assess 4 
the identity of the sequences obtained with those held in GenBank database.   5 
 6 
RESULTS  7 
EPS isolation 8 
 EPS fractions were isolated from Bifidobacterium strains grown in MRSC plates 9 
instead of a liquid medium in order to avoid the co-isolation of glucomannans present in the 10 
yeast extract added to MRS (45). The production was low, and ranged from 0.78 to 4.34 mg 11 
per plate depending on the strain, with a protein content in fractions between 1.9 and 8.9 % 12 
(data not shown).  13 
  14 
Evolution of SCFA in fecal batch cultures     15 
 Fecal batch cultures with added EPS displayed pH values between 6 and 7 from the 16 
beginning to the 5th day of incubation (data not shown). However, cultures with glucose and 17 
inulin which showed initial pH values between 6 and 7 decreased to between 4 and 5 or 5 and 18 
6 after 5 days of incubation, respectively.  19 
 There was evidence of difference among the individuals with respect to the levels of 20 
SCFA attained in fecal cultures, individual 2 being the highest producer for all EPS tested but 21 
not for inulin and glucose (data not shown). However, we used the mean data from donors for 22 
subsequent comparisons in order to facilitate the analyses (Table 2). 23 
 Total SCFA increased during the first 24 h of incubation of fecal microbiota with and 24 
without external carbon sources added (Table 2). Acetic acid was the most abundant, 25 
 10 
followed by similar amounts of both propionic acid and butyric acid. Minor amounts of other 1 
acids such as isobutyric, isovaleric, valeric, and caproic were also identified (data not shown). 2 
However, the increase of SCFA levels was considerably more pronounced in the presence of 3 
glucose, inulin and EPS than in the control, thus indicating a stimulation of the SCFA 4 
production from external carbon sources added. During incubation, the highest production of 5 
total SCFA was obtained with polymers C52 from B. pseudocatenulatum, E44 from B. 6 
longum, and E43 from B. animalis, which indicates that SCFA production was probably more 7 
related with the polymer composition than with the producer strain.  8 
 In general, the molar proportion of acetic acid decreased during incubation with EPS 9 
and inulin but increased with glucose. The contrary occurred for propionic acid which 10 
increased during incubation whilst butyric acid increased or decreased moderately depending 11 
on the compound (Table 2). Different fermentation patterns were thus seen according to the 12 
carbohydrate used. The highest molar proportion of propionic acid was obtained for the EPS 13 
isolated from the four strains of the species B. longum followed by the strain B. 14 
pseudocatenulatum C52. On 5th day of fermentation these five polymers clearly promoted 15 
higher molar proportions of propionic acid than inulin. The molar proportion of acetic acid in 16 
cultures with glucose was higher, and that of propionic and butyric acids lower, than in 17 
cultures with inulin and EPS. Remarkably, as a consequence of the SCFA production pattern 18 
just commented above, the acetic to propionic acid ratio decreased during incubation with the 19 
EPS tested and inulin, whereas a clear increase of this ratio was found in cultures with 20 
glucose. In this respect, it is worth noting that the lowest values for the acetic / propionic ratio 21 
(values around 2 on the 5th day of incubation, which were lower than those found for inulin) 22 
were obtained with EPS isolated from strains of the species B. longum (E44, H67, H73, and 23 
L55) and from B. pseudocatenulatum C52.    24 
 25 
 11 
Changes in Bifidobacterium population analysed by quantitative real time PCR 1 
 Quantitative real-time PCR analyses were performed to evaluate the bifidogenic 2 
effect of the EPS isolated from intestinal bifidobacteria (Figure 1). After 1 or 5 days of 3 
incubation all EPS tested, as well as glucose and inulin, promoted higher increases of 4 
bifidobacteria populations than those occurring in control cultures without carbohydrates 5 
added, which was indicative of a stimulatory effect of these substrates on bifidobacteria. The 6 
increase of bifidobacteria population promoted specifically by EPS was in the range of that 7 
promoted by inulin. In general, the highest stimulation after 1 day of incubation was promoted 8 
by glucose, followed by inulin and EPS from B. pseudocatenulatum C52 although a great 9 
interindividual variability was found. After 5 days of incubation the strongest stimulation 10 
corresponded again to glucose followed by inulin and different EPS depending on the 11 
individual. The lowest initial count of bifidobacteria in fecal samples generally resulted in the 12 
highest count increase after incubation.  13 
 14 
Changes in fecal microbial cultures analysed by PCR-DGGE 15 
 PCR-DGGE was used as a molecular technique to monitor major qualitative changes 16 
in the composition of microbial groups in fecal batch cultures (Figure 2). Subsequent 17 
amplification and sequencing of several bands from DGGE gels allowed the identification of 18 
several microbial groups present in the cultures (Table 3), some of which were related with 19 
moderate differences in profiles seen through incubation. Most noticeable changes found in 20 
cultures during incubation are summarized in Table 4. Figure 2a shows DGGE banding 21 
patterns of control cultures without carbohydrate added in feces from two individuals since 22 
the behaviour in samples from the third one followed a similar pattern to the others (data not 23 
shown). Initial differences between donors and moderate variations after 5 days of incubation 24 
were found. These differences were mainly related to the disappearance or attenuation of 25 
 12 
several upper bands (numbers 2, 3, 7, 8, and 9) that matched with different Bacteroides 1 
species. Therefore, changes occurring in the same way as those just commented above were 2 
inherent to interindividual variability and to the methodology used and were not considered as 3 
related to the carbon sources added. In spite of that, in cultures with glucose, band 3 remained 4 
clearly visible throughout incubation which indicates that glucose positively contributed to 5 
the survival of some microorganisms related to Bacteroides vulgatus.  6 
 Moderate differences in DGGE banding patterns among fecal batch cultures with 7 
EPS were found throughout incubation (Figure 2b, c, d; Table 4). These differences were 8 
mainly related to different fingerprintings of feces among different donors on the first day of 9 
incubation and to a reduction of band diversity on the 5th day. Most clear and EPS-specific 10 
noticeable changes are commented on next.  11 
 In the presence of polymers from B. longum strains H67 and L55 (Figure 2b) band 12 
18, which matched with Anaerostipes caccae / Clostridium polysaccharolyticum, appeared 13 
reinforced in fecal cultures of individual 2. One band -marked as 4- also became more intense 14 
in fecal cultures of two donors (1 and 3) during incubation with H67 and this band displayed 15 
homology with Prevotella copri. The same occurred for band 11 in fecal cultures of 16 
individuals 1 and 2 with EPS L55 and in this case the band matched to Oscillospira 17 
guilliermondii. Band 12, also related to O. guilliermondii, weakened in feces from donors 2 18 
and 3 with the EPS from B. longum E44 (Figure 2c) whereas band 23 which was closely 19 
related to Oscillibacter valericigenes became enriched in feces from individual 2 during 20 
incubation with the same polysaccharide E44. Incubation with the three EPS from B. longum 21 
strains tested (H67, L55, and E44) promoted in fecal cultures from some donors an initial 22 
increase in intensity of bands 21 and/or 22 related to Escherichia coli / Shigella flexneri but 23 
the intensity of one or both bands decreased notably after 5 days of incubation. Major bands 24 
found after 5 days of incubation of fecal samples with EPS isolated from B. longum strains 25 
 13 
included members of Bacteroides / Prevotella, E. coli related bacteria, Oscillospira / 1 
Oscillibacter, and Anaerostipes / Clostridium polysaccharolyticum.  2 
 With respect to the EPS from the strain B. animalis E43 (Figure 2d), a decrease in 3 
intensity of bands 21, 22, and 30 (related to E. coli / S. flexneri) was seen in fecal cultures of 4 
individual 1 at the end of incubation. Changes in intensity (increases or decreases) of bands 9 5 
and 10, matching with Bacteroides uniformis, were also found depending on individuals. 6 
Nevertheless, major bands identified after 5 days of incubation corresponded to 7 
microorganisms of the genus Bacteroides and E. coli and related microorganisms.  8 
 Finally, EPS C52 and E63 from B. pseudocatenulatum (Figure 2c, d) were related to 9 
increases or decreases in the intensity of bands 21 and 22 matching with E. coli / S. flexneri. 10 
Remarkably, during incubation with the EPS E63 band 17- identified as Faecalibacterium 11 
prausnitzii (100% identity) - and band 20- sharing homology with the species Desulfovibrio 12 
piger- became slightly more intense on fecal cultures from individual 1, and from individuals 13 
1 and 2, respectively. With EPS C52 band 11- related to O. guillermondii - decreased in 14 
intensity during incubation in fecal cultures of the three individuals whereas with EPS E63 it 15 
remained clearly visible during the incubation of feces from donor 2. At the end of incubation 16 
major bands in cultures of EPS from B. pseudocatenulatum were related to the group of 17 
Bacteroides, E. coli, F. prausnitzii, Desulfovibrio, and Oscillospira.  18 
 19 
DISCUSSION 20 
 Genetic studies (36) and preliminary analyses carried out by us on the composition of 21 
EPS from human intestinal bifidobacteria indicated that they are heteropolysaccharides 22 
containing glucose, galactose, and in several cases also rhamnose. The low production of EPS 23 
obtained for most intestinal bifidobacteria is in agreement with that previously reported by 24 
other authors, who indicated that heteropolysaccharides are produced in considerably lower 25 
 14 
amounts than homopolysaccharides (5, 44).  1 
 We observed the effects of EPS isolated from bifidobacteria in terms of metabolic 2 
activity and composition of the microbial community in fecal slurry cultures. Firstly, all 3 
carbohydrates used seemed to act as fermentable substrates for the intestinal microbiota, 4 
clearly enhancing the production of SCFA during incubation. Levels of SCFA attained in 5 
fecal cultures with EPS were comparable to that obtained with the prebiotic inulin. Similarly 6 
to that previously indicated by other workers, incubation with glucose gave rise to more acetic 7 
but less propionic and butyric production than other fermentable substrates (34, 46). The 8 
lower pH values found by us in cultures with glucose and inulin, with respect to the cultures 9 
with EPS were probably due to a greater stimulation by the former substrates of growth 10 
and/or metabolic activity of intestinal bacteria. However, a shift to butyrate production was 11 
not evident in these mostly acidic cultures with glucose and inulin, as indicated to occur by 12 
Walker et al. (47) when the pH of fecal cultures decrease to values lower than 6. Molar 13 
proportions of the different SCFA measured in our fecal cultures were within the same order 14 
of that reported by others. Thus, most authors indicated that acetic acid is produced at higher 15 
levels than propionic and butyric acids (1, 4, 9, 25, 46). Incubation of the intestinal microbiota 16 
in the presence of our EPS or inulin promoted a shift in the SCFA profile of fecal cultures, 17 
causing a decrease through incubation of molar proportions of acetic acid, an increase of 18 
propionic acid, decreases or moderate increases of butyric acid, and a reduction of the acetic 19 
to propionic acids ratio through time. This behaviour was contrary to that found in cultures 20 
with glucose, carbohydrate not considered as prebiotic and for which a clear increase of acetic 21 
to propionic ratio was obtained through fermentation. Increases in total SCFA production 22 
with shifts towards propionic and butyric acids were previously reported for inulin in a 23 
simulator of the human intestinal microbial ecosystem (43). The reduction of the acetic to 24 
propionic ratio has been proposed as a possible indicator of the hypolipidemic effect 25 
 15 
(inhibition of cholesterol and fatty acids biosynthesis in liver which finally results in a 1 
decrease of lipid levels in blood) of prebiotics (11). Remarkably, the highest decrease of this 2 
ratio was obtained by us for the four cultures with EPS from the species B. longum and with 3 
the EPS C52 from B. pseudocatenulatum. Interestingly, values for acetic / propionic ratio of 4 
these five EPS were even lower than those obtained by us for the prebiotic inulin. However, 5 
although EPS-producer microorganisms were isolated from different human individuals (10) 6 
and in spite of the different percentage of monosaccharides in their composition (data not 7 
shown), the identical chemical nature of these polymers cannot be absolutely discarded.  8 
 The bifidogenic effect of EPS was shown by real-time quantitative PCR analyses that 9 
showed a moderate increase of bifidobacteria during the incubation of the fecal slurry 10 
cultures. The degree of stimulation depended on the EPS and the donor and was lower than 11 
that obtained with glucose, being comparable in general to that found with inulin. 12 
Bifidobacteria have been described as beneficially affected by inulin and inulin-derived 13 
substrates (24, 48). Stimulation of intestinal bifidobacteria population has been shown before 14 
for an oat-based product cofermented with a β-glucan -producing Pediococcus damnosus 15 
strain (30). A bifidogenic effect was also demonstrated for a levan-type and a fructan-type 16 
EPS produced by two strains of Lactobacillus sanfranciscensis (8, 27) from food origin. 17 
However, the bifidogenic effect of EPS produced by intestinal bifidobacteria has not been 18 
previously reported. Nevertheless, since bifidobacteria are acetate and lactate producers, 19 
beneficial shifts in SCFA profiles found by us in fecal cultures do not only point towards a 20 
unique bifidogenic effect but also to the modification of other microbial groups that may use 21 
acetate and produce propionate or butyrate via a metabolic cross-feeding mechanism (2, 14, 22 
15).  23 
 PCR-DGGE is a useful technique for the examination of the diversity within 24 
microbial communities. In fecal slurry cultures the use of universal primers allows the 25 
 16 
monitoring of some microbial groups and to obtain an overview of major qualitative changes 1 
affecting them. We were not able to identify bifidobacteria with this technique, probably due 2 
to a limitation of the universal primers and experimental conditions used in this work. The use 3 
of EPS isolated from intestinal bifidobacteria as carbon source gave rise to a reduction in 4 
variability of bands and to an enrichment of some microbial populations other than 5 
bifidobacteria, as previously found by Dal Bello et al. (8) with the EPS produced by L. 6 
sanfranciscensis. All amplicons sequenced in our study showed homology with members of 7 
the indigenous gut microbiota previously found by other authors (21, 41, 49). Major groups 8 
represented included members of Bacteroides, Clostridium leptum (cluster IV), Clostridium 9 
coccoides (cluster XIVa) and γ-proteobacteria. In our case, global changes in cultures with 10 
EPS mainly affected Bacteroides and E. coli and relatives. Thus, sequencing of the DNA 11 
fragment bands pointed to a reduction of several populations of E. coli / S. flexneri after 12 
incubation with polymers from B. longum and B. animalis. For polymers from B. 13 
pseudocatenulatum, increases or decreases in the intensity of several bands matching with E. 14 
coli/ S. flexneri were found, suggesting a rearrangement of populations from this group. Some 15 
other interesting features were also found with EPS from B. pseudocatenulatum and B. 16 
longum. Regarding the polymers from the first species, a moderate increase in the intensity of 17 
bands corresponding to Desulfovibrio and F. prausnitzii was found during incubation. F. 18 
prausnitzii is an established member of the dominant human fecal microbiota able to produce 19 
butyrate, lactate and formate, that needs acetate in the medium for growth (12). In addition, it 20 
has been demonstrated that Desulfovibrio had an important role in the turnover of SCFA in 21 
the colon (17). Chemostat culture experiments corroborated these findings and indicated that 22 
sulfate-reducing bacteria like Desulfovibrio and others promoted a shift in the metabolism of 23 
sugars, altering the synthesis by saccharolytic microorganisms of hydrolytic enzymes 24 
involved in carbohydrate breakdown (33). It is thus possible that the high SCFA level, low 25 
 17 
acetic / propionic ratio and high bifidogenic effect obtained with the EPS produced by the 1 
strain B. pseudocatenulatum C52 could be related to a positive interaction between this 2 
polymer, saccharolytic microorganisms related to Bacteroides or other groups, and sulfate-3 
reducing populations from fecal cultures. With respect to EPS from B. longum, during 4 
incubation they seem to support populations of Anaerostipes, Prevotella, and/or Oscillospira, 5 
depending on the polymer used. Oscillospira is a microorganism which has not been grown in 6 
pure culture yet. It is found in the rumen of several animals (29) and it has been also 7 
recovered from the human large intestine by using 16S rDNA clone libraries (21). Members 8 
of the genus Prevotella, as happens with its neighbour Bacteroides, are saccharolytic versatile 9 
microorganism able to utilise a wide variety of carbohydrates as fermentable carbon sources 10 
(23, 37, 38). In the appropriate conditions, Prevotella is able to produce propionate (40). 11 
Traditionally isolated from ruminal material, several strains of this genus have recently been 12 
recovered from human feces and proposed as new species (22). Anaerostipes is a common 13 
inhabitant of the human gut, it is an efficient lactate converter (14) and is able to produce 14 
butyrate from lactate formed by bifidobacteria in cocultures (2). Metabolic cross-feeding 15 
between different members of the colon microbiota has been suggested as a possible 16 
mechanism responsible for colonic butyrate and propionate production (2, 3, 14). Two types 17 
of cross-feeding mechanisms have recently been described between Bifidobacterium and 18 
butyrate-forming bacteria, one due to consumption of fermentation end products (lactate and 19 
acetate) and the other due to cross-feeding of partial breakdown products formed from 20 
complex carbohydrates (2).  21 
 Interactions among acetate or lactate-formers, poly or oligosaccharide-degraders and 22 
butyrate or propionate-producers, or even more complex relationships as those that can occur 23 
between sulfate-reducing bacteria and other microorganisms can be established among 24 
intestinal microbial populations as affected by the carbon sources available. These 25 
 18 
interactions promoted by microbial EPS could have accounted for in vitro shifts in SCFA 1 
profiles, increase of bifidobacteria, and changes in intestinal microbial patterns of fecal 2 
cultures found in the present work. Sugars such as glucose are not abundant in the gut but 3 
other complex polymers present in the diet such as inulin can reach this location, or even 4 
others such as microbial EPS may be synthesised in this environment. Therefore, it is 5 
reasonable to suppose that EPS from intestinal bifidobacteria could act as fermentable 6 
substrates in vivo, promoting shifts in SCFA profiles and changes in the relationships among 7 
intestinal microbial populations. In this way, a WHO Experts Group have recently 8 
recommended to revise the definition of prebiotics by considering not only the effect on 9 
bifidobacteria and lactobacilli but also broadening it to other ecological interactions among 10 
members of the human microbiota (50).  11 
 12 
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Table 1. Identification by partial sequencing the 16S rRNA V1-V2 gene region of the EPS-1 
producing Bifidobacterium strains from human intestinal origin employed in this study.  2 
Species Strain Origin 
(human) 
GenBank accession 
number 
B. animalis C64MR Rectal mucose EU430030 
 E43 Feces EU430031 
B. pseudocatenulatum A102 Feces EU430027 
 C52 Feces EU430029 
 E63 Feces EU430025 
 E515 Feces EU430026 
 H34G Feces EU430028 
B. longum E44 Feces EU430035 
 H67 Feces EU430032 
 H73 Feces EU430033 
 L55 Feces EU430034 
 3 
 4 
 5 
 6 
Table 2. Molar concentrations and proportions of the three major SCFA in fecal cultures from three donors using glucose, inulin or EPS from bifidobacteria as carbon sources 1 
Carbon source Strain Time 
(d)  
Acetate 
(mM) 
Propionate 
(mM) 
Butyrate 
(mM) 
Total SCFA 
(mM) 
 Acetate % Propionate  % Butyrate % Acetic/propionic  
Control (without 
carbohydrate added) 
 0 
1 
5 
4.03±1.65 
8.50±0.57 
8.27±1.42 
0.96±0.36 
2.27±0.26 
1.90±0.61 
1.20±0.37 
3.03±0.48 
2.27±0.71 
 6.18±2.36 
13.80±1.07 
12.44±1.67 
 64.51±2.44 
61.64±2.19 
66.53±7.18 
15.56±1.50 
16.51±1.73 
14.97±3.19 
19.93±2.09 
21.86±1.93 
18.50±5.85 
4.18±0.46 
3.77±0.46 
4.68±1.32 
EPS isolated from  
B. animalis 
C64MR 1 
5 
15.63±5.75 
13.79±1.94 
4.77±1.50 
3.99±0.95 
4.24±1.27 
3.79±1.36 
24.64±8.38 
21.57±3.61 
 63.02±3.29 
64.40±6.26 
19.54±1.79 
18.35±2.16 
17.43±1.68 
17.25±4.45 
3.26±0.44 
3.60±0.87 
 E43 1 
5 
17.96±7.11 
14.89±3.14 
5.40±1.93 
4.68±0.93 
4.63±1.61 
4.44±1.64 
27.99±10.60 
24.01±5.16 
 63.85±1.86 
62.23±5.74 
19.44±0.80 
19.59±1.84 
16.71±1.16 
18.18±4.44 
3.29±0.22 
3.23±0.62 
EPS isolated from  
B. pseudocatenulatum 
A102 1 
5 
12.95±3.84 
13.22±2.22 
4.08±1.56 
5.01±0.77 
3.94±1.24 
4.69±0.87 
20.98±6.59 
22.92±3.58 
 62.03±2.36 
57.65±3.13 
19.12±1.33 
21.88±1.21 
18.85±1.61 
20.47±2.51 
3.26±0.33 
2.65±0.26 
 C52 1 
5 
17.25±6.17 
14.24±3.74 
6.13±1.89 
5.99±1.04 
5.28±1.51 
5.99±1.19 
28.66±9.30 
26.22±5.86 
 59.89±4.35 
53.91±3.03 
21.46±1.74 
23.07±1.26 
18.65±2.67 
23.02±1.99 
2.82±0.44 
2.35±0.25 
 E63 1 
5 
14.01±5.49 
11.39±1.60 
4.49±1.41 
4.03±1.17 
4.14±1.52 
3.54±1.05 
22.63±8.35 
18.96±2.99 
 61.50±2.87 
60.80±5.98 
20.21±2.23 
20.91±3.47 
18.29±0.85 
18.29±3.01 
3.09±0.45 
3.01±0.73 
 E515 1 
5 
14.30±2.92 
12.87±2.88 
4.56±1.02 
4.70±1.40 
4.79±1.40 
4.52±1.29 
23.65±5.25 
22.09±5.01 
 60.72±1.88 
58.49±5.53 
19.28±0.70 
21.01±1.80 
20.01±1.68 
20.49±4.52 
3.16±0.18 
2.82±0.49 
 H34G 1 
5 
13.50±4.88 
10.99±2.10 
4.44±1.72 
3.62±1.26 
4.18±1.49 
3.92±1.59 
22.12±8.06 
18.54±4.65 
 61.00±1.76 
60.75±7.55 
19.98±0.73 
19.07±3.26 
19.02±1.28 
20.18±4.75 
3.06±0.19 
3.33±0.96 
EPS isolated from  
B. longum 
E44 1 
5 
14.57±4.20 
15.00±3.50 
5.22±1.47 
6.73±1.85 
4.36±1.20 
5.04±1.67 
24.15±6.69 
26.81±6.87 
 60.28±2.28 
56.35±3.61 
21.68±2.57 
25.14±1.81 
18.04±1.37 
18.51±2.08 
2.83±0.48 
2.26±0.31 
 H67 1 
5 
11.98±1.73 
12.15±3.56 
3.57±0.53 
5.81±1.40 
3.74±0.78 
4.04±1.61 
19.29±2.89 
22.01±6.03 
 62.20±2.59 
55.04±2.90 
18.54±1.50 
26.64±1.74 
19.26±1.46 
18.31±1.44 
3.38±0.40 
2.08±0.24 
 H73 1 
5 
12.81±2.96 
12.33±2.29 
3.70±0.89 
4.99±1.38 
3.78±1.10 
4.00±1.28 
20.29±4.85 
21.32±4.84 
 63.25±2.52 
58.46±4.34 
18.30±1.99 
23.13±1.73 
18.44±1.17 
18.41±2.61 
3.50±0.45 
2.56±0.43 
 L55 1 
5 
11.38±3.51 
11.76±2.33 
3.48±1.07 
5.39±1.18 
3.67±1.06 
4.93±0.88 
18.53±5.50 
22.08±4.09 
 61.24±4.04 
53.23±3.56 
18.86±2.52 
24.29±1.15 
19.90±1.58 
22.47±2.87 
3.33±0.67 
2.20±0.24 
Glucose  1 
5 
14.45±3.90 
14.66±2.75 
2.73±0.53 
2.42±0.44 
2.48±0.82 
3.32±2.58 
19.65±4.14 
20.41±2.28 
 72.89±6.65 
72.15±12.19 
13.97±1.56 
11.84±1.54 
13.13±5.15 
16.01±11.37 
5.32±1.05 
6.26±1.69 
Inulin  1 
5 
14.36±0.39 
14.44±4.33 
5.18±1.24 
5.14±1.70 
4.57±2.16 
5.16±2.63 
24.10±2.76 
24.74±3.41 
 60.22±6.70 
57.64±13.55 
21.40±4.36 
20.45±4.48 
18.39±6.64 
21.91±12.86 
2.95±0.84 
3.02±1.26 
Table 3. Bacteria identified by sequencing the DGGE bands amplified by PCR from DNA of fecal batch 
cultures using the universal 16S rRNA gene-targeted primers 357F and 518R.  
 
Nº Band 
in Fig. 2 
Closest sequence found in Genbank database 
(% similarity) 1 
Accesion 
number 
Closest known species 
(% similarity) 1 
Accesión number 
 
1 Uncultured bacterium clone SJTU C02 96  (91%) EF403967 Bacteroides  uniformis  (90%) AB247146 
2 Uncultured bacterium clone L243  (94%) AY983015 
 
Bacteroides vulgatus  (94%) EU136687 
 
3 Uncultured Bacteroidales bacterium clone MS104A1 
(97%) 
EF703593 
 
Bacteroides vulgatus  (97%) EU136687 
 
4 Uncultured bacterium clone SSH 51  (100%) EU268853 
 
Prevotella copri  (96%) AB244773 
5 Uncultured Bacteroidales bacterium clone MS146A1 
B01  (99%) 
EF706714 
 
Bacteroides vulgatus  (99%) CP000139 
 
6 Uncultured bacterium clone LZ51  (97%) AY976451 
 
Prevotella copri  (94%) 
 
AB244772 
 
7 Uncultured bacterium clone SSH 65  (90%) EU268866 
 
Bacteroides plebeius  (90%) AB200217 
 
8 Uncultured Bacteroidales bacterium clone pigH8 
(92%) 
AY695697 
 
Bacteroides thetaiotamicron / Bacteroides 
acidofaciens  (91%) 
AY895189 / AB021164 
 
9 Bacteroides uniformis strain JCM5828  (93%) EU136680 
 
  
10 Bacteroides uniformis strain JCM5828  (99%) EU136680 
 
  
11 Uncultured Lachnospiraceae bacterium clone 
MS069A1 F08  (96%) 
EF706465 
 
Oscillospira guilliermondii  (96%) AB040499 
 
12 Uncultured Lachnospiraceae bacterium clone 
MS069A1 F08  (96%) 
EF706465 
 
Oscillospira guilliermondii  (97%) AB040499 
 
13 Uncultured Lachnospiraceae bacterium clone 
MS146A1 E12   (93%) 
EF706759 
 
Clostridium coccoides  (92%) 
 
EF025906 
 
14 Clostridium symbiosium strain 69  (99%) EF025909 
 
  
15 Uncultured bacterium clone RL181 aan97c06  (100%) DQ798481 Ruminococcus gauvreaui / Coprococcus 
comes (100%) 
EF529620 / EF031542 
16 Uncultured bacterium clone NA 35  (100%) AY975545 
 
Coprococcus catus  (100%) ABO38359 
 
17 Uncultured bacterium clone RL185 aan87f05  (100%) DQ825275 Faecalibacterium prausnitzii  (100%) 
 
AJ413954 
 
18 Uncultured Ruminococcus sp isolate DGGE gel band 
51v3  (98%) 
 
EF587944 
 
Anaerostipes caccae / Clostridium 
polysaccharolyticum  (98%) 
AB243986 / X77839 
 
19 Ruminococcus sp.WAL 14507  (100%) EF036467 
 
Peptostreptococcus productus / 
Ruminococcus obeum  (100%) 
AM117591/AY169419 
 
20 Uncultured bacterium clone SJTU C0806  (99%) 
 
EF404297 
 
Desulfovibrio piger  (98%) 
 
AF192152 
 
21 Uncultured bacterium clone isolate DGGE gel band 
wj22  (97%) 
EF489276 
 
Escherichia coli / Shigella flexneri  (97%) CP000800 / CP000266 
 
22 Uncultured bacterium clone isolate DGGE gel band 
wj22  (100%) 
EF489276 
 
Escherichia coli / Shigella flexneri  (98%) EU330541 / CP000266 
23 Uncultured bacterium clone SJTU C06 05  (100%) EF404193 
 
Oscillibacter valericigenes  (97%) AB238598 
 
24 Uncultured Lachnospiraceae bacterium clone 
MS135A1 G06  (98%) 
EF706692 
 
Clostridium orbiscindens / Eubacterium 
plautii  (97%) 
AY730665 / AY724678 
 
25 Uncultured bacterium  clone API13S48  (93%) AM277960 
 
Clostridium leptum  (96%) 
 
AJ305238 
 
26 Citrobacter freundii strain SW3 /  
Kluyvera ascorbata strain CDC 0648/74  (98%) 
EU124385 
AF176560 
 
 
 
27 Uncultured bacterium clone RL 188 aan96f11  (100%) DQ802797 
 
Dialister invisus  (99%) AY162469 
 
28 Uncultured Lachnospiraceae bacterium clone 
MS146A1 D07  (100%) 
EF706742 
 
Clostridium orbiscindens / Eubacterium 
plautii  (100%) 
AY730665 / AY724678 
 
29 Dialister invisus  (96%) 
 
AY162469 
 
  
30 Uncultured bacterium G3 clone 24  (100%) EF149169 Escherichia coli / Shigella flexneri  (99%) AM779083 / CP000266 
1
 Accesion numbers were determined by searching in GenBank database using the local BLAST program. We selected as closest 
relatives those sequences showing maximum identity among those displaying maximum coverage when aligned with sequences 
from PCR-DGGE amplicons.  
 
 1 
Table 4.  Main PCR-DGGE bands showing changes (variation of intensity, appearance or 
disappearance) in fecal cultures from three donors during incubation with several EPS from 
bifidobacteria used as carbon sources.   
 
 
Carbon source Strain Individual 1 Individual 2 Individual 3 
Control (without carbohydrate 
added) 
 2, 3, 7, 8, 9  2, 3, 7, 8, 9 
EPS from B. longum  H67 4, 21, 22 18, 21, 22 4 
 L55 11, 21, 22 11, 18, 21, 22  
 E44 21, 22 12, 23 12 
EPS from B. animalis E43 9, 10, 21, 22, 30 9, 10 9 
EPS from B. pseudocatenulatum  C52 11, 21, 22 11, 21, 22 11 
 E63 17, 20, 21, 22 11, 20, 21, 22  
FIGURE LEGENDS 1 
Figure 1. Increase with respect to time 0 of Bifidobacterium counts measured by quantitative 2 
real-time PCR in fecal slurry cultures from three donors using glucose, inulin or EPS isolated 3 
from intestinal bifidobacteria as carbon sources after 24 h (a) and 5 days (b) of incubation. 4 
Control does not include carbohydrate source added. Initial Log CFU/ml Bifidobacterium 5 
counts: donor 1 (white bars) = 9.56 ± 0.10, donor 2 (grey bars) = 10.61 ± 0.14 and donor 3 6 
(black bars) = 9.93 ± 0.08.  7 
Figure 2. DGGE profiles of fecal cultures from three donors using glucose, inulin or EPS 8 
isolated from intestinal bifidobacteria as carbon sources at time 0, and after 1 and 5 days of 9 
incubation. Numbers (1, 2 and 3) between brackets indicate different donors. (a) Control 10 
culture without carbohydrate added; Gluc.: glucose and Inul.: inulin; (b) EPS isolated from B. 11 
longum H67 and B. longum L55; (c) EPS isolated from B. pseudocatenulatum C52 and B. 12 
longum E44; (d) EPS isolated from B. pseudocatenulatum E63 and B. animalis E43. The 13 
point 0d corresponds to the initial microbiota of each donor before incubation. Numbers 14 
inside gels refer to sequenced DNA bands, whose amplicons and closest relatives are 15 
indicated in Table 3. BL: B. longum, BP: B. pseudocatenulatum, BA: B. animalis.  16 
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